Literature DB >> 3871795

Effects of in vitro corticosteroids on B cell activation, proliferation, and differentiation.

T R Cupps, T L Gerrard, R J Falkoff, G Whalen, A S Fauci.   

Abstract

The present study demonstrates the graded effect of in vitro corticosteroids (CSs) on the different phases of B cell activation, proliferation, and differentiation. Early events such as activation and proliferation of high-dose anti-mu or Staphylococcus aureus-stimulated B cells are profoundly suppressed by the presence of in vitro CSs. The suppressed proliferative response may be mediated by a direct effect on B cells and/or modulation of accessory cell function. Later events in the B cell cycle such as the proliferative response to B cell growth factor after either in vivo or in vitro activation are less sensitive to the suppressive effects of in vitro CSs. The final events in the B cell cycle; namely, the differentiation to the immunoglobulin-producing state, is not suppressed by in vitro CSs. Indeed, depending on the systems employed, there is either no effect or enhancement of immunoglobulin secretion by the presence of in vitro CSs. The graded effect of in vitro CSs on the discrete phases of the B cell activation, proliferation, and differentiation cycle provide new insights into the complex nature of CS-induced modulation of human B cell responses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871795      PMCID: PMC423574          DOI: 10.1172/JCI111757

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Steroid sensitivity of the PHA and PWM responses of fractionated human lymphocytes in vitro.

Authors:  H Blomgren; B Andersson
Journal:  Exp Cell Res       Date:  1976-02       Impact factor: 3.905

2.  Clinical considerations in the use of corticosteroids.

Authors:  G W Thorn
Journal:  N Engl J Med       Date:  1966-04-07       Impact factor: 91.245

3.  Conditions for induction of specific and polyclonal antibody production by Cowan 1 bacteria and by pokeweed mitogen.

Authors:  O Sjöberg; J Kurnick
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

4.  Effect of hydrocortisone on immunoglobulin synthesis and secretion by human peripheral lymphocytes in vitro.

Authors:  R S Smith; N A Sherman; E Middleton
Journal:  Int Arch Allergy Appl Immunol       Date:  1972

5.  The effect of hydrocortisone on the incorporation of tritiated thymidine by human blood lymphocytes cultured with phytohaemagglutinin and pokeweed mitogen.

Authors:  D H Heilman; M R Gambrill; J P Leichner
Journal:  Clin Exp Immunol       Date:  1973-10       Impact factor: 4.330

6.  Triggering mechanism of B lymphocytes. I. Effect of anti-immunoglobulin and enhancing soluble factor on differentiation and proliferation of B cells.

Authors:  T Kishimoto; T Miyake; Y Nishizawa; T Watanabe; Y Yamamura
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

7.  Activation of human B lymphocytes. IV. Regulatory effects of corticosteroids on the triggering signal in the plaque-forming cell response of human peripheral blood B lymphocytes to polyclonal activation.

Authors:  A S Fauci; K R Pratt; G Whalen
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

Review 8.  Glucocorticosteroid therapy: mechanisms of action and clinical considerations.

Authors:  A S Fauci; D C Dale; J E Balow
Journal:  Ann Intern Med       Date:  1976-03       Impact factor: 25.391

9.  Human B cell differentiation. IV. Effect of monoclonal anti-immunoglobulin M and D antibodies on B cell proliferation and differentiation induced by T cell factors.

Authors:  T Kuritani; M D Cooper
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

10.  Selective suppression of an early step in human B cell activation by cyclosporin A.

Authors:  A Muraguchi; J L Butler; J H Kehrl; R J Falkoff; A S Fauci
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  33 in total

1.  Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques.

Authors:  E K Page; A J Page; J Kwun; A C Gibby; F Leopardi; J B Jenkins; E A Strobert; M Song; R A Hennigar; N Iwakoshi; S J Knechtle
Journal:  Am J Transplant       Date:  2012-07-09       Impact factor: 8.086

Review 2.  Effect of Immunosuppressive Drugs on Humoral Allosensitization after Kidney Transplant.

Authors:  Olivier Thaunat; Alice Koenig; Claire Leibler; Philippe Grimbert
Journal:  J Am Soc Nephrol       Date:  2016-02-12       Impact factor: 10.121

Review 3.  The role of B cells in multiple sclerosis: Current and future therapies.

Authors:  Austin Negron; Rachel R Robinson; Olaf Stüve; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2018-10-21       Impact factor: 4.868

4.  Lack of glucocorticoid-induced leucine zipper (GILZ) deregulates B-cell survival and results in B-cell lymphocytosis in mice.

Authors:  Stefano Bruscoli; Michele Biagioli; Daniele Sorcini; Tiziana Frammartino; Monica Cimino; Paolo Sportoletti; Emanuela Mazzon; Oxana Bereshchenko; Carlo Riccardi
Journal:  Blood       Date:  2015-08-14       Impact factor: 22.113

5.  Corticosteroids inhibit anti-IgE activities of specialized proresolving mediators on B cells from asthma patients.

Authors:  Nina Kim; Thomas H Thatcher; Patricia J Sime; Richard P Phipps
Journal:  JCI Insight       Date:  2017-02-09

6.  Glucocorticoids enhance concanavalin A-induced mitogenic response through the inhibition of nitric oxide production.

Authors:  F Ramírez; A Silva
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

7.  A limiting-dilution analysis of activated circulating B cells in Crohn's disease.

Authors:  M Boirivant; F Quintieri; O Pugliese; G Famularo; S Fais; F Pallone
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

8.  Mechanism of action of glucocorticoid-induced immunoglobulin production: II. Requirement for fetal calf serum.

Authors:  S Sierakowski; J S Goodwin
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

Review 9.  Immunology of idiopathic nephrotic syndrome.

Authors:  Manuela Colucci; Giorgia Corpetti; Francesco Emma; Marina Vivarelli
Journal:  Pediatr Nephrol       Date:  2017-04-27       Impact factor: 3.714

10.  Development of specific antibody and in vivo response to antigen in different rat strains: effect of dexamethasone and importance of endogenous corticosteroids.

Authors:  S H Peers; G S Duncan; R J Flower
Journal:  Agents Actions       Date:  1993-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.